224 related articles for article (PubMed ID: 38601153)
1. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
[TBL] [Abstract][Full Text] [Related]
2. Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.
Asthana A; Ramakrishnan P; Vicioso Y; Zhang K; Parameswaran R
Mol Cancer Ther; 2018 Oct; 17(10):2226-2237. PubMed ID: 30082471
[TBL] [Abstract][Full Text] [Related]
3. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
4. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
[TBL] [Abstract][Full Text] [Related]
5. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
6. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
7. Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling.
Luanpitpong S; Rodboon N; Samart P; Janan M; Klaihmon P; Lorthongpanich C; U-Pratya Y; Issaragrisil S
Stem Cells; 2022 Dec; 40(12):1078-1093. PubMed ID: 36124999
[TBL] [Abstract][Full Text] [Related]
8. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
9. Too sweet to resist: Control of immune cell function by O-GlcNAcylation.
de Jesus T; Shukla S; Ramakrishnan P
Cell Immunol; 2018 Nov; 333():85-92. PubMed ID: 29887419
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.
Spaner DE
Front Immunol; 2021; 12():772304. PubMed ID: 34868034
[TBL] [Abstract][Full Text] [Related]
11. Hexosamine biosynthetic pathway and
Kim DY; Park J; Han IO
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
[TBL] [Abstract][Full Text] [Related]
13. OGT upregulates myogenic IL-6 by mediating O-GlcNAcylation of p65 in mouse skeletal muscle under cold exposure.
Hu Y; Liu Y; Yang Y; Lv H; Lian S; Xu B; Li S
J Cell Physiol; 2022 Feb; 237(2):1341-1352. PubMed ID: 34668190
[TBL] [Abstract][Full Text] [Related]
14. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.
Parker MP; Peterson KR; Slawson C
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244
[TBL] [Abstract][Full Text] [Related]
17. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
18. Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway.
Zhang B; Zhou P; Li X; Shi Q; Li D; Ju X
Am J Cancer Res; 2017; 7(6):1337-1349. PubMed ID: 28670495
[TBL] [Abstract][Full Text] [Related]
19. Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.
Munemoto M; Mukaisho KI; Miyashita T; Oyama K; Haba Y; Okamoto K; Kinoshita J; Ninomiya I; Fushida S; Taniura N; Sugihara H; Fujimura T
Cancer Sci; 2019 Aug; 110(8):2408-2420. PubMed ID: 31215094
[TBL] [Abstract][Full Text] [Related]
20. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.
Yang YR; Kim DH; Seo YK; Park D; Jang HJ; Choi SY; Lee YH; Lee GH; Nakajima K; Taniguchi N; Kim JM; Choi EJ; Moon HY; Kim IS; Choi JH; Lee H; Ryu SH; Cocco L; Suh PG
Oncotarget; 2015 May; 6(14):12529-42. PubMed ID: 25915426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
